{
  "id": "5aa395fcd6d6b54f79000007",
  "type": "yesno",
  "question": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)",
  "ideal_answer": "The use of rituximab may be of benefit for CFS/ME, but the evidence of its effectiveness is still limited.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28052319"
  ],
  "snippets": [
    {
      "text": " The use of rintatolimod and rituximab as well as counselling, behavioural and rehabilitation therapy programs may be of benefit for CFS/ME, but the evidence of their effectiveness is still limited. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28052319",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}